BioCentury | Aug 18, 2016
Emerging Company Profile

Negative thinking for brain cancer

...renal and thyroid cancers and is in Phase I trials for refractory neuroblastoma by the New Approaches to Neuroblastoma Therapy Consortium...
...Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Bayer AG (Xetra:BAYN), Leverkusen, Germany Columbia University, New York, N.Y. New Approaches to Neuroblastoma Therapy Consortium...
Items per page:
1 - 1 of 1
BioCentury | Aug 18, 2016
Emerging Company Profile

Negative thinking for brain cancer

...renal and thyroid cancers and is in Phase I trials for refractory neuroblastoma by the New Approaches to Neuroblastoma Therapy Consortium...
...Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Bayer AG (Xetra:BAYN), Leverkusen, Germany Columbia University, New York, N.Y. New Approaches to Neuroblastoma Therapy Consortium...
Items per page:
1 - 1 of 1